Silencing of this gene dramatically reduced resistance of CRC cells to fluorouracil and oxaliplatin [71] and lowered the level of anti-apoptotic BCL2 protein in CRC and other types of cancer [72]. Here, BCL2 is linked to colorectal carcinoma.